A cocktail of AMA1 proteins of a few different strains can be effective in overcoming major limitations of earlier versions of AMA1 based malaria vaccine, a new study conducted by researchers, ...
A safe and effective malaria vaccine is high on the wish list of most people concerned with global health. New results suggest how a leading vaccine candidate could be vastly improved. A safe and ...
An experimental vaccine designed to spur production of antibodies against a key malaria parasite protein, AMA1, was developed more than decade ago. It showed promise in test-tube and animal ...
Writing in Cell Reports, researchers from the National Institute of Allergy and Infectious Diseases (NIAID) and collaborators have presented a multifaceted analysis and structure-function study of a ...
This work, published on 10th October on the website of Nature Communications, concerns the role of one protein which is common to these parasites. Called AMA1, it has been at the heart of many years' ...
Blood-stage malaria vaccines are intended to prevent clinical disease. The malaria vaccine FMP2.1/AS02 A, a recombinant protein based on apical membrane antigen 1 (AMA1) from the 3D7 strain of ...
Proceedings of the National Academy of Sciences of the United States of America, Vol. 97, No. 26 (Dec. 19, 2000), pp. 14548-14553 (6 pages) Meiosis is the developmental program by which diploid ...
A safe and effective malaria vaccine is high on the wish list of most people concerned with global health. Results published on December 26 in PLOS Pathogens suggest how a leading vaccine candidate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results